Related Experiment Video
Updated: Mar 29, 2026

04:41
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
Published on: March 10, 2023
1.8K
Liver transplantation for hepatocellular carcinoma
Wentao Jiang1, Jiang Li, Qingjun Guo
1Department of Transplant Surgery, Tianjin First Central Hospital.
Drug Discoveries & Therapeutics
|December 4, 2015
Summary
Advances in liver transplantation improve outcomes for liver cancer patients. Rigorous patient selection and addressing organ shortages are key to maximizing long-term survival and societal benefit.
Area of Science:
- Hepatobiliary Surgery
- Transplantation Medicine
- Oncology
Background:
- Liver transplantation techniques have significantly improved patient prognosis for liver cancer.
- A critical shortage of donor organs in China presents a major challenge.
- Optimizing outcomes requires careful patient selection and addressing organ scarcity.
Purpose of the Study:
- To explore strategies for improving long-term survival in liver cancer patients undergoing transplantation.
- To address the organ shortage issue in China through enhanced transplantation approaches.
- To investigate methods for preventing and treating cancer recurrence post-transplantation.
Main Methods:
- Review of current liver transplantation techniques and outcomes.
- Analysis of patient selection criteria for liver cancer.
- Discussion of strategies for utilizing marginal donor livers.
- Examination of post-transplantation cancer recurrence factors.
Main Results:
- Improved surgical techniques have enhanced patient survival rates.
- Rigorous patient selection is crucial for favorable long-term outcomes.
- Utilizing marginal donor organs is a potential solution to the organ shortage.
Conclusions:
- Further research into cancer recurrence mechanisms is vital.
- Optimizing pre-transplantation strategies and post-transplantation care is essential.
- Developing techniques for marginal donor liver transplantation is key to overcoming organ scarcity and improving clinical benefits for hepatocellular carcinoma patients.

